These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29587614)

  • 1. Pharmacogenomics in IVF: A New Era in the Concept of Personalized Medicine.
    Kalinderi K; Asimakopoulos B; Nikolettos N; Manolopoulos VG
    Reprod Sci; 2019 Oct; 26(10):1313-1325. PubMed ID: 29587614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of FSHR diplotypes on ovarian response to standard gonadotropin stimulation for IVF/ICSI.
    Lazaros L; Hatzi E; Xita N; Takenaka A; Sofikitis N; Zikopoulos K; Georgiou I
    J Reprod Med; 2013; 58(9-10):395-401. PubMed ID: 24050028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today?
    Altmäe S; Hovatta O; Stavreus-Evers A; Salumets A
    Hum Reprod Update; 2011; 17(6):813-28. PubMed ID: 21862569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of allelic combinations of FSHR gene polymorphisms with ovarian response.
    Desai SS; Achrekar SK; Paranjape SR; Desai SK; Mangoli VS; Mahale SD
    Reprod Biomed Online; 2013 Oct; 27(4):400-6. PubMed ID: 23953588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.
    Huang X; Li L; Hong L; Zhou W; Shi H; Zhang H; Zhang Z; Sun X; Du J
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):577-83. PubMed ID: 25132286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics in ovarian stimulation--current concepts.
    Loutradis D; Vlismas A; Drakakis P; Antsaklis A
    Ann N Y Acad Sci; 2008 Apr; 1127():10-9. PubMed ID: 18443324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic profile of SNP(s) and ovulation induction.
    Loutradis D; Theofanakis C; Anagnostou E; Mavrogianni D; Partsinevelos GA
    Curr Pharm Biotechnol; 2012 Mar; 13(3):417-25. PubMed ID: 21657995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism FSHR (-29G/A) as a genetic agent together with ESRI (XbaIG/A) in women with poor response to controlled ovarian hyperstimulation.
    Zamaniara T; Taheripanah R; Ghaderian SMH; Zamaniara E; Aghabozorgi SSA
    Hum Antibodies; 2017; 26(3):143-147. PubMed ID: 29526845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of estrogen, progesterone and follicle stimulating hormone receptor polymorphisms with in vitro fertilization outcomes.
    Ganesh V; Venkatesan V; Koshy T; Reddy SN; Muthumuthiah S; Paul SFD
    Syst Biol Reprod Med; 2018 Aug; 64(4):260-265. PubMed ID: 29916276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of gene polymorphisms and AMH level in prediction of poor ovarian response in Egyptian women undergoing IVF procedure.
    Motawi TMK; Rizk SM; Maurice NW; Maged AM; Raslan AN; Sawaf AH
    J Assist Reprod Genet; 2017 Dec; 34(12):1659-1666. PubMed ID: 28825151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization.
    La Marca A; Sighinolfi G; Argento C; Grisendi V; Casarini L; Volpe A; Simoni M
    Fertil Steril; 2013 Mar; 99(4):970-8.e1. PubMed ID: 23380184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics in ovarian stimulation - current concepts and future options.
    Greb RR; Behre HM; Simoni M
    Reprod Biomed Online; 2005 Nov; 11(5):589-600. PubMed ID: 16409708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of FSHR variants and antimüllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation.
    Binder H; Strick R; Zaherdoust O; Dittrich R; Hamori M; Beckmann MW; Oppelt PG
    Fertil Steril; 2012 May; 97(5):1169-75.e1. PubMed ID: 22401810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicle-stimulating hormone receptor polymorphism (G-29A) is associated with altered level of receptor expression in Granulosa cells.
    Desai SS; Achrekar SK; Pathak BR; Desai SK; Mangoli VS; Mangoli RV; Mahale SD
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2805-12. PubMed ID: 21752882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic estrogen receptor 1 (ESR1) gene variants predict the outcome of ovarian stimulation in in vitro fertilization.
    Altmäe S; Haller K; Peters M; Hovatta O; Stavreus-Evers A; Karro H; Metspalu A; Salumets A
    Mol Hum Reprod; 2007 Aug; 13(8):521-6. PubMed ID: 17540666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of ovarian response.
    Lledo B; Ortiz JA; Llacer J; Bernabeu R
    Pharmacogenomics; 2014 Apr; 15(6):885-93. PubMed ID: 24897293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ala307Thr and Asn680Ser polymorphisms of FSHR gene in human reproduction outcomes.
    Trevisan CM; Peluso C; Cordts EB; de Oliveira R; Christofolini DM; Barbosa CP; Bianco B
    Cell Physiol Biochem; 2014; 34(5):1527-35. PubMed ID: 25322982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of FSHR rs6165 and ESR2 rs4986938 polymorphisms in ovarian stimulation of Iranian women who underwent assisted reproduction treatment.
    Kaviani M; Ghaderian SMH; Arefi S; Hashemi M; Afjeh SSA
    Hum Antibodies; 2017; 26(3):121-126. PubMed ID: 29036809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicle-stimulating hormone receptor gene polymorphisms are not associated with ovarian reserve markers.
    Mohiyiddeen L; Newman WG; McBurney H; Mulugeta B; Roberts SA; Nardo LG
    Fertil Steril; 2012 Mar; 97(3):677-81. PubMed ID: 22265040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.